pramipexol ratiopharm 0.52 mg depottabletti
ratiopharm gmbh - pramipexolum dihydrochloridum monohydricum - depottabletti - 0.52 mg - pramipeksoli
pramipexol ratiopharm 1.05 mg depottabletti
ratiopharm gmbh - pramipexolum dihydrochloridum monohydricum - depottabletti - 1.05 mg - pramipeksoli
pramipexol ratiopharm 1.57 mg depottabletti
ratiopharm gmbh - pramipexolum dihydrochloridum monohydricum - depottabletti - 1.57 mg - pramipeksoli
pramipexol ratiopharm 2.1 mg depottabletti
ratiopharm gmbh - pramipexolum dihydrochloridum monohydricum - depottabletti - 2.1 mg - pramipeksoli
pramipexol ratiopharm 2.62 mg depottabletti
ratiopharm gmbh - pramipexolum dihydrochloridum monohydricum - depottabletti - 2.62 mg - pramipeksoli
pramipexol ratiopharm 3.15 mg depottabletti
ratiopharm gmbh - pramipexolum dihydrochloridum monohydricum - depottabletti - 3.15 mg - pramipeksoli
delamonie 75 mikrog tabletti, kalvopäällysteinen
sandoz a/s sandoz a/s - desogestrelum - tabletti, kalvopäällysteinen - 75 mikrog - desogestreeli
desirett 75 mikrog tabletti, kalvopäällysteinen
exeltis healthcare s.l. - desogestrel - tabletti, kalvopäällysteinen - 75 mikrog - desogestreeli
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroxysmal - immunosuppressantit - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
noradrenalin hameln 0.2 mg/ml infuusioneste, liuos
hameln pharma gmbh - noradrenaline tartrate - infuusioneste, liuos - 0.2 mg/ml - noradrenaliini